FREE Account Opening + No Clearing Fees
Loading...

Garv Industries IPO vs Indo US BioTech IPO

Comparision between Garv Industries IPO and Indo US BioTech IPO.

IPO Details

Garv Industries IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Indo US BioTech IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Garv Industries IPO Indo US BioTech IPO
Logo Garv Industries IPO Logo Indo US BioTech IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Aryaman Financial Services Limited Swastika Investmart Ltd
Registrar Skyline Financial Services Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Garv Industries IPO is up to ₹3.20 Cr whereas the issue size of the Indo US BioTech IPO is up to ₹7.29 Cr. The final issue price of Garv Industries IPO is ₹10.00 per share and of Indo US BioTech IPO is ₹51.00 per share.

  Garv Industries IPO Indo US BioTech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹10.00 per share ₹51.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 10000 shares 2000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 32,00,000 shares 14,30,000 shares
Issue Size Total (Amount) up to ₹3.20 Cr up to ₹7.29 Cr

IPO Timetable

Garv Industries IPO opens on Apr 12, 2018, while Indo US BioTech IPO opens on Apr 30, 2018. The closing date of Garv Industries IPO and Indo US BioTech IPO is Apr 17, 2018, and May 03, 2018, respectively.

  Garv Industries IPO Indo US BioTech IPO
Anchor Bid Date
Issue Open Apr 12, 2018 Apr 30, 2018
Issue Close Apr 17, 2018 May 03, 2018
Basis Of Allotment (Tentative) Apr 20, 2018
Initiation of Refunds (Tentative) Apr 23, 2018
Credit of Share (Tentative) Apr 24, 2018
Listing date (Tentative) Apr 25, 2018
Anchor Lockin End date 1 May 20, 2018
Anchor Lockin End date 2 Jul 19, 2018

Financials

Garv Industries IPO P/E ratio is , as compared to Indo US BioTech IPO P/E ratio of .

  Garv Industries IPO Indo US BioTech IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Jan-18
Total Assets 1,036.35
Total Revenue 1,459.18
Profit After Tax 11.43
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,293.66 1,368.76 767.52 605.19 626.38
Total Revenue 2,457.79 1,914.53 1,966.07 1,485.50 1,493.84
Profit After Tax 64.99 35.99 49.59 25.96 29.94
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Garv Industries IPO retail investors (RII) are offered 15,91,500 shares while in Indo US BioTech IPO retail investors are offered 15,91,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Garv Industries IPO and 0 shares in Indo US BioTech IPO.

  Garv Industries IPO Indo US BioTech IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,70,000 shares 74,000 shares
QIB 0 shares 0 shares
NII 15,91,500 shares 6,78,000 shares
RII 15,91,500 shares 6,78,000 shares
Employee
Others
Total 32,00,000 shares 14,30,000 shares

Bids Received (Subscription)

Garv Industries IPO subscribed 2.13x in total, whereas Indo US BioTech IPO subscribed 19.74x.

  Garv Industries IPO Indo US BioTech IPO
QIB (times)
NII (times) 2.17x 19.52x
Big NII (times)
Small NII (times)
RII (times) 1.89x 19.87x
Employee (times)
Other (times)
Total (times) 2.13x 19.74x

Comments

Add a public comment...